James Moy to Immunologic Factors
This is a "connection" page, showing publications James Moy has written about Immunologic Factors.
Connection Strength
0.573
-
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga?) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study. J Clin Immunol. 2017 Aug; 37(6):603-612.
Score: 0.573